Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Effect of St John's wort on imatinib mesylate pharmacokinetics.

Frye RF, Fitzgerald SM, Lagattuta TF, Hruska MW, Egorin MJ.

Clin Pharmacol Ther. 2004 Oct;76(4):323-9.

PMID:
15470331
2.

The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).

Markowitz JS, DeVane CL.

Psychopharmacol Bull. 2001 Winter;35(1):53-64. Review.

PMID:
12397870
3.

Pharmacokinetic interactions of drugs with St John's wort.

Zhou S, Chan E, Pan SQ, Huang M, Lee EJ.

J Psychopharmacol. 2004 Jun;18(2):262-76. Review.

PMID:
15260917
4.

St John's Wort supplements endanger the success of organ transplantation.

Ernst E.

Arch Surg. 2002 Mar;137(3):316-9. Review.

PMID:
11888457
5.

St. John's wort: a new alternative for depression?

Josey ES, Tackett RL.

Int J Clin Pharmacol Ther. 1999 Mar;37(3):111-9. Review.

PMID:
10190758
6.

About the cover: St. John's wort.

[No authors listed]

J Soc Integr Oncol. 2006 Winter;4(1):52-5. Review.

PMID:
16737673
7.

St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.

Barnes J, Anderson LA, Phillipson JD.

J Pharm Pharmacol. 2001 May;53(5):583-600. Review.

PMID:
11370698
8.

[St. John's wort (Hypericum perforatum L.). A plant with relevance for dermatology].

Schempp CM, Müller KA, Winghofer B, Schöpf E, Simon JC.

Hautarzt. 2002 May;53(5):316-21. Review. German.

PMID:
12063742
9.

Efficacy and safety of St. John's wort for the treatment of major depression.

Nangia M, Syed W, Doraiswamy PM.

Public Health Nutr. 2000 Dec;3(4A):487-94. Review.

PMID:
11276296
10.

Drug interactions with St John's wort : mechanisms and clinical implications.

Mannel M.

Drug Saf. 2004;27(11):773-97. Review.

PMID:
15350151
11.

Usefulness of studies on the molecular mechanism of action of herbals/botanicals: The case of St. John's wort.

Choudhuri S, Valerio LG Jr.

J Biochem Mol Toxicol. 2005;19(1):1-11. Review.

PMID:
15736155
12.

St John's wort (Hypericum perforatum) in major depression.

Shelton RC.

J Clin Psychiatry. 2009;70 Suppl 5:23-7. doi: 10.4088/JCP.8157su1c.05. Review.

PMID:
19909690
13.

Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence.

Izzo AA.

Int J Clin Pharmacol Ther. 2004 Mar;42(3):139-48. Review.

PMID:
15049433
14.

A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review.

Whiskey E, Werneke U, Taylor D.

Int Clin Psychopharmacol. 2001 Sep;16(5):239-52. Review.

PMID:
11552767
15.

Clinical pharmacokinetics of imatinib mesylate.

Levêque D, Maloisel F.

In Vivo. 2005 Jan-Feb;19(1):77-84. Review.

16.

Potential for interaction of kava and St. John's wort with drugs.

Singh YN.

J Ethnopharmacol. 2005 Aug 22;100(1-2):108-13. Review.

PMID:
16005588
17.

St John's wort for depression: a systematic review.

Gaster B, Holroyd J.

Arch Intern Med. 2000 Jan 24;160(2):152-6. Review.

PMID:
10647752
18.

[Adverse drug effects and interactions. What is the current thinking about the use of St. John's wort?].

Johne A, Roots I.

Pharm Unserer Zeit. 2003;32(3):242-6. Review. German. No abstract available.

PMID:
12784545
19.

Pharmacokinetic interactions between herbal remedies and medicinal drugs.

Ioannides C.

Xenobiotica. 2002 Jun;32(6):451-78. Review.

PMID:
12160480
20.

Nilotinib: a second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia.

Deremer DL, Ustun C, Natarajan K.

Clin Ther. 2008 Nov;30(11):1956-75. doi: 10.1016/j.clinthera.2008.11.014. Review.

PMID:
19108785

Supplemental Content

Support Center